Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 14/20 | 0.46 |
| ▸ | CCKAR | P32238 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9802689 | 1.00 | CCKBR (0.46) | CCKBRCCKARALDH1A1CHRM2CHRM4 | |
| SCHEMBL9802697 | 1.00 | CCKBR (0.46) | CCKBRCCKARALDH1A1CHRM2CHRM4 | |
| SCHEMBL9802399 | 1.00 | CCKBR (0.46) | CCKBRCCKARALDH1A1CHRM2CHRM4 | |
| SCHEMBL9801983 | 0.99 | CCKBR (0.46) | CCKBRCCKARALDH1A1CHRM2CHRM4 | |
| SCHEMBL9802646 | 0.99 | CCKBR (0.46) | CCKBRCCKARALDH1A1CHRM2CHRM4 | |
| SCHEMBL9802635 | 0.99 | CCKBR (0.46) | CCKBRCCKARALDH1A1CHRM2CHRM4 | |
| SCHEMBL9801974 | 0.99 | CCKBR (0.46) | CCKBRCCKARALDH1A1CHRM2CHRM4 | |
| SCHEMBL9802171 | 0.89 | PYGL (0.41) | CCKBR | |
| SCHEMBL9802290 | 0.89 | PYGL (0.41) | CCKBR | |
| SCHEMBL9802184 | 0.89 | PYGL (0.41) | CCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5055464-A | Cognition activators, diuretics, antiulcer agents | YOSHITOMI PHARMACEUTICAL INDUSTRIES LTD. (JP) | 1991-10-08 | — | — | US | disclosed |
| EP-0322779-A2 | Benzolactam compounds and pharmaceutical uses thereof | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1989-07-05 | — | — | EP | disclosed |